Company Valifarm Srl with Fiscal Code 110895
recorded a turnover of 2024 of
86.816,
with a net profit of
-10.197
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Valifarm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
167.548
167.877
171.428
181.295
175.547
227.208
271.270
326.217
333.635
86.816
Total Income - EUR
167.562
167.893
171.439
181.305
175.681
227.221
271.287
326.239
333.651
103.830
Total Expenses - EUR
164.647
166.597
169.350
179.953
172.506
219.150
261.227
325.235
324.810
112.392
Gross Profit/Loss - EUR
2.915
1.296
2.089
1.352
3.175
8.071
10.060
1.005
8.840
-8.562
Net Profit/Loss - EUR
2.439
973
501
320
2.690
7.438
9.097
49
7.137
-10.197
Employees
3
3
3
3
2
2
2
2
2
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -73.8%, from 333.635 euro in the year 2023, to 86.816 euro in 2024.
The Net Profit decreased by -7.097 euro, from 7.137 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Valifarm Srl
Financial Rating - VALIFARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Valifarm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Valifarm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Valifarm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
77.260 euro in 2024 which includes Inventories of
6.548 euro, Receivables of
9.175 euro and cash availability of
61.536 euro.
The company's Equity was valued at
90.211 euro, while total Liabilities amounted to
284 euro.
Equity decreased by -10.197 euro, from 100.972 euro in 2023, to 90.211 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Valifarm Srl